Prevalence of anti-hepatitis A antibodies, hepatitis B viral markers and anti-hepatitis C antibodies among persons with intellectual disability in institutions in Israel

Joav Merrick; Mohammed Morad; Edna Ben Porath

doi:10.1080/13668250220135079-3

Prevalence of anti-hepatitis A antibodies, hepatitis B viral markers and anti-hepatitis C antibodies among persons with intellectual disability in institutions in Israel

Joav Merrick, Mohammed Morad, Edna Ben Porath

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

The purpose of this study was to determine the prevalence of antibodies to hepatitis A, B and C in persons with intellectual disability in residential care in Israel and especially to determine the need for immunisation against hepatitis A. Four residential care centres were chosen from 53 centres housing 6022 persons. A total of 251 participants was tested and the prevalence of anti-hepatitis A virus was 91%, of hepatitis B surface antigen was 5.2%, its corresponding anti-HBs was 57% and of anti-hepatitis C virus was 0.8%. It is concluded that active immunisation against hepatitis B should be continued in this population, but only each new person who enters the residential care centres from home should be vaccinated against hepatitis A.

Original language	English
Pages (from-to)	85-91
Number of pages	7
Journal	Journal of Intellectual and Developmental Disability
Volume	27
Issue number	2
DOIs	https://doi.org/10.1080/13668250220135079-3
State	Published - 1 Jan 2002
Externally published	Yes

ASJC Scopus subject areas

Education
Arts and Humanities (miscellaneous)
General Psychology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1080/13668250220135079-3

Cite this

@article{a96e7f5038f84c1e89ca5c48ad5167b8,

title = "Prevalence of anti-hepatitis A antibodies, hepatitis B viral markers and anti-hepatitis C antibodies among persons with intellectual disability in institutions in Israel",

abstract = "The purpose of this study was to determine the prevalence of antibodies to hepatitis A, B and C in persons with intellectual disability in residential care in Israel and especially to determine the need for immunisation against hepatitis A. Four residential care centres were chosen from 53 centres housing 6022 persons. A total of 251 participants was tested and the prevalence of anti-hepatitis A virus was 91%, of hepatitis B surface antigen was 5.2%, its corresponding anti-HBs was 57% and of anti-hepatitis C virus was 0.8%. It is concluded that active immunisation against hepatitis B should be continued in this population, but only each new person who enters the residential care centres from home should be vaccinated against hepatitis A.",

author = "Joav Merrick and Mohammed Morad and Porath, {Edna Ben}",

year = "2002",

month = jan,

day = "1",

doi = "10.1080/13668250220135079-3",

language = "English",

volume = "27",

pages = "85--91",

journal = "Journal of Intellectual and Developmental Disability",

issn = "1366-8250",

publisher = "Informa Healthcare",

number = "2",

}

Prevalence of anti-hepatitis A antibodies, hepatitis B viral markers and anti-hepatitis C antibodies among persons with intellectual disability in institutions in Israel. / Merrick, Joav; Morad, Mohammed; Porath, Edna Ben.
In: Journal of Intellectual and Developmental Disability, Vol. 27, No. 2, 01.01.2002, p. 85-91.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Prevalence of anti-hepatitis A antibodies, hepatitis B viral markers and anti-hepatitis C antibodies among persons with intellectual disability in institutions in Israel

AU - Merrick, Joav

AU - Morad, Mohammed

AU - Porath, Edna Ben

PY - 2002/1/1

Y1 - 2002/1/1

N2 - The purpose of this study was to determine the prevalence of antibodies to hepatitis A, B and C in persons with intellectual disability in residential care in Israel and especially to determine the need for immunisation against hepatitis A. Four residential care centres were chosen from 53 centres housing 6022 persons. A total of 251 participants was tested and the prevalence of anti-hepatitis A virus was 91%, of hepatitis B surface antigen was 5.2%, its corresponding anti-HBs was 57% and of anti-hepatitis C virus was 0.8%. It is concluded that active immunisation against hepatitis B should be continued in this population, but only each new person who enters the residential care centres from home should be vaccinated against hepatitis A.

AB - The purpose of this study was to determine the prevalence of antibodies to hepatitis A, B and C in persons with intellectual disability in residential care in Israel and especially to determine the need for immunisation against hepatitis A. Four residential care centres were chosen from 53 centres housing 6022 persons. A total of 251 participants was tested and the prevalence of anti-hepatitis A virus was 91%, of hepatitis B surface antigen was 5.2%, its corresponding anti-HBs was 57% and of anti-hepatitis C virus was 0.8%. It is concluded that active immunisation against hepatitis B should be continued in this population, but only each new person who enters the residential care centres from home should be vaccinated against hepatitis A.

UR - http://www.scopus.com/inward/record.url?scp=0036086346&partnerID=8YFLogxK

U2 - 10.1080/13668250220135079-3

DO - 10.1080/13668250220135079-3

M3 - Article

AN - SCOPUS:0036086346

SN - 1366-8250

VL - 27

SP - 85

EP - 91

JO - Journal of Intellectual and Developmental Disability

JF - Journal of Intellectual and Developmental Disability

IS - 2

ER -

Prevalence of anti-hepatitis A antibodies, hepatitis B viral markers and anti-hepatitis C antibodies among persons with intellectual disability in institutions in Israel

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this